Characteristic of DTI datasets, where different colors denotes similarities derived from data diverse sources.
Dataset . | NR . | GPCR . | IC . | E . | Luo . |
---|---|---|---|---|---|
Drug | 54 | 223 | 210 | 445 | 708 |
Target | 26 | 95 | 204 | 664 | 1512 |
Interaction | 166 | 1096 | 2331 | 4256 | 1923 |
Sparsity | 0.118 | 0.052 | 0.054 | 0.014 | 0.002 |
Drug Similarity (Source) |$^\ddag$| | SIMCOMP, LAMBDA, MARG, MINMAX, SPEC, TAN (CS) ; AERS-b, AERS-f, SIDER (SE) | TAN (CS), DDI, DIA, SE | |||
Target Similarity (Source)|$^\S$| | SW, MIS-k3m1, MIS-k4m1, MIS-k3m2, MIS-k4m2, SPEC-k3, SPEC-k4 (AAS) ; PPI; GO | SW (AAS), PPI, TIA |
Dataset . | NR . | GPCR . | IC . | E . | Luo . |
---|---|---|---|---|---|
Drug | 54 | 223 | 210 | 445 | 708 |
Target | 26 | 95 | 204 | 664 | 1512 |
Interaction | 166 | 1096 | 2331 | 4256 | 1923 |
Sparsity | 0.118 | 0.052 | 0.054 | 0.014 | 0.002 |
Drug Similarity (Source) |$^\ddag$| | SIMCOMP, LAMBDA, MARG, MINMAX, SPEC, TAN (CS) ; AERS-b, AERS-f, SIDER (SE) | TAN (CS), DDI, DIA, SE | |||
Target Similarity (Source)|$^\S$| | SW, MIS-k3m1, MIS-k4m1, MIS-k3m2, MIS-k4m2, SPEC-k3, SPEC-k4 (AAS) ; PPI; GO | SW (AAS), PPI, TIA |
|$\ddag$| CS: chemical structure, SE: drug side effect, DDI: drug–drug interaction, DIA: drug–disease association |$\S$| AAS: amino-acid sequence, PPI: protein–protein interaction, GO: Gene Ontology annotation, TIA: target–disease association
Characteristic of DTI datasets, where different colors denotes similarities derived from data diverse sources.
Dataset . | NR . | GPCR . | IC . | E . | Luo . |
---|---|---|---|---|---|
Drug | 54 | 223 | 210 | 445 | 708 |
Target | 26 | 95 | 204 | 664 | 1512 |
Interaction | 166 | 1096 | 2331 | 4256 | 1923 |
Sparsity | 0.118 | 0.052 | 0.054 | 0.014 | 0.002 |
Drug Similarity (Source) |$^\ddag$| | SIMCOMP, LAMBDA, MARG, MINMAX, SPEC, TAN (CS) ; AERS-b, AERS-f, SIDER (SE) | TAN (CS), DDI, DIA, SE | |||
Target Similarity (Source)|$^\S$| | SW, MIS-k3m1, MIS-k4m1, MIS-k3m2, MIS-k4m2, SPEC-k3, SPEC-k4 (AAS) ; PPI; GO | SW (AAS), PPI, TIA |
Dataset . | NR . | GPCR . | IC . | E . | Luo . |
---|---|---|---|---|---|
Drug | 54 | 223 | 210 | 445 | 708 |
Target | 26 | 95 | 204 | 664 | 1512 |
Interaction | 166 | 1096 | 2331 | 4256 | 1923 |
Sparsity | 0.118 | 0.052 | 0.054 | 0.014 | 0.002 |
Drug Similarity (Source) |$^\ddag$| | SIMCOMP, LAMBDA, MARG, MINMAX, SPEC, TAN (CS) ; AERS-b, AERS-f, SIDER (SE) | TAN (CS), DDI, DIA, SE | |||
Target Similarity (Source)|$^\S$| | SW, MIS-k3m1, MIS-k4m1, MIS-k3m2, MIS-k4m2, SPEC-k3, SPEC-k4 (AAS) ; PPI; GO | SW (AAS), PPI, TIA |
|$\ddag$| CS: chemical structure, SE: drug side effect, DDI: drug–drug interaction, DIA: drug–disease association |$\S$| AAS: amino-acid sequence, PPI: protein–protein interaction, GO: Gene Ontology annotation, TIA: target–disease association
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.